Ortin Laboratories Limited (ORTINLAB.NS) NSE

20.33

-0.04(-0.20%)

Updated at September 02, 2024 03:29PM

Currency In INR

Valuation

Market Cap149.6M
Enterprise Value144.2M
P/E Ratio-2.06
PEG Ratio0.02
Price/Sales Ratio7.83
Price/Book Ratio5.85
Enterprise/Revenue7.57
Enterprise/EBITDA-2.51

Fiscal Year

Fiscal YearMarch 31, 2024
Most Recent QuarterMarch 31, 2024

Profitability

Profit Margin-3.81
Operating Margin-3.2

Management Effectiveness

Return On Assets-1.21
Return On Equity-1.17

Income Statement

Revenue21.12M
Revenue/Share2.6
Gross Profit-23.94M
EBITDA-63.65M
Net Income-80.41M
Diluted EPS-9.89

Balance Sheet

Total Cash23.43M
Total Cash/Share2.88
Total Debt18.02M
Total Debt/Equity0.64
Current Ratio3.11
Book Value Per Share3.47

Price History

52-Week Change3.99
52-Week High26.35
52-Week Low16.2
Moving Average 50 Days20.24
Moving Average 200 Days20.07

Statistics

Average Volume118,301
Shares Outstanding8.13M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor12:25
Last Split DateJanuary 12, 2021